Birdwatch Note
2024-12-14 05:36:00 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
"Ivermectin could reduce the risk of MV requirement and AEs in patients with COVID-19, without increasing other risks. In the absence of a better alternative, clinicians could use it with caution." https://pubmed.ncbi.nlm.nih.gov/38510038/
Written by 6D95675C42E34D1C4F28133254B88B10D7CBBAF2C623BDD6CB2F2EC0ECBC5A08
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1867311443013701832
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1867805722093977844
- noteId - 1867805722093977844
- participantId -
- noteAuthorParticipantId - 6D95675C42E34D1C4F28133254B88B10D7CBBAF2C623BDD6CB2F2EC0ECBC5A08 Participant Details
- createdAtMillis - 1734154560957
- tweetId - 1867311443013701832
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- "Ivermectin could reduce the risk of MV requirement and AEs in patients with COVID-19, without increasing other risks. In the absence of a better alternative, clinicians could use it with caution." https://pubmed.ncbi.nlm.nih.gov/38510038/